Back to search

Testosterone and Gonadotrophin Profiles in Patients on Daily or Monthly LHRH Analogue ICI 118630 (Zoladex) Compared with Orchiectomy

Data up to Jan 2025

Published1986
Citations22
References21

Total Citations Per Year

Abstract

References (21)

Carcinoma of the Prostate: Treatment Comparisons

1967 • 209 citations

Inhibitory Effects of Long Term Treatment with a Luteinizing Hormone-Releasing Hormone Agonist on the Pituitary-Gonadal Axis in Male and Female Rats

1979 • 137 citations

Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men

1982 • 125 citations

Long Term Effects of Administration of a Gonadotropin Releasing Hormone Superagonist Analog in Men with Prostatic Carcinoma

1984 • 100 citations

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

1984 • 99 citations

Cardiovascular Complications in the Treatment of Prostatic Carcinoma

1981 • 92 citations

Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

1983 • 78 citations

TREATMENT OF ADVANCED PROSTATIC CANCER WITH LHRH ANALOGUE ICI 118630: CLINICAL RESPONSE AND HORMONAL MECHANISMS

1983 • 67 citations

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

1984 • 65 citations

Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.

1985 • 60 citations

Inhibition of Pituitary-Testicular Function with [D-Trp6] Luteinizing Hormone-Releasing Hormone in Rhesus Monkeys*

1982 • 50 citations

Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.

1985 • 49 citations

New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen

1983 • 47 citations

Bilateral orchiectomy for carcinoma of prostate Response of serum testosterone and clinical Response to subsequent estrogen therapy

1981 • 40 citations

Endocrine and clinical effects of leuprolide in prostatic cancer

1984 • 31 citations

A RADIOIMMUNOASSAY FOR GnRH AGONIST ANALOGUE IN SERUM OF PATIENTS WITH PROSTATE CANCER TREATED WITH D‐Ser (tBu)6AZA Gly10 GnRH

1985 • 27 citations

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.

1984 • 21 citations

Plasma androgen levels after subcapsular orchiectomy or estrogen treatment for prostatic carcinoma

1982 • 17 citations

Hormonal Pattern in Prostatic Carcinoma following Orchidectomy: 5-Year Follow-up

1977 • 15 citations

A New Hormonal Therapy for Prostatic Cancer: Long‐term Clinical and Hormonal Response

1986 • 15 citations

Effects of Total and Subcapsular Orchidectomy on Serum Concentrations of Testosterone and Pituitary Hormones in Patients with Carcinoma of the Prostate

1982 • 13 citations

Cited By (0)

Loading...
Testosterone and Gonadotrophin Profiles in Patients on Daily or Monthly LHRH Analogue ICI… (1986) – British Journal of Urology | Metascience Observatory Explorer